As filed with the U.S. Securities and Exchange Commission on January 28, 2026. Registration No. 333-290759 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Peace Acquisition Corp (Exact name of registrant as specified in its charter) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) (Name, address, including zip code, and telephone number, including area c ...

MIXED MARTIAL ARTS GROUP LIMITED (Exact name of Registrant as specified in its charter) As filed with the Securities and Exchange Commission on January 26, 2026. Registration Statement No. 333-292799 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Australia 7380 Not applicable (I.R.S ...

Company Performance - Spring Valley Acquisition Corp. III Warrants (NASDAQ:SVACW) experienced a significant price increase of 294.23%, reaching $2.05, potentially driven by speculative trading or news related to their energy and decarbonization operations [1][6] - 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) saw its stock price rise by 144.5% to $4.89, likely benefiting from positive clinical trial developments or regulatory approvals, despite a 1-4 reverse stock split leading to a 2.4% decline ahead of the event [2] - IO Biotech, Inc. (NASDAQ:IOBT) had a stock price increase of 102.12%, reaching $0.41, with investor optimism possibly fueled by its focus on immune-modulating cancer therapies and exploration of strategic alternatives [3][6] - Namib Minerals Warrants (NASDAQ:NAMMW) recorded an 88.68% increase to $0.34, influenced by its involvement in gold and critical green metals production and exploration, while Namib Minerals Ordinary Shares (NASDAQ:NAMM) rose by 77.47% to $4.01, possibly due to favorable mining outcomes or strategic acquisitions [4] Market Dynamics - The recent stock price movements highlight the dynamic nature of the market, where company developments, industry trends, and investor sentiment play crucial roles in influencing stock prices [5]

As filed with the U.S. Securities and Exchange Commission on January 20, 2026. Registration No. 333-290759 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Peace Acquisition Corp (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Cayman Islands 6770 N/A (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identifica ...

Core Viewpoint - Foresight Group Holdings Limited has issued a correction regarding its share buyback program, clarifying the total number of shares purchased to date under the program announced on April 10, 2025 [1]. Group 1: Share Buyback Program - On January 2, 2026, the company corrected the total number of shares purchased under the buyback program to 2,662,129 Ordinary Shares as of December 31, 2025 [1]. - On January 5, 2026, the company updated the total number of shares purchased under the buyback program to 2,675,111 Ordinary Shares as of January 2, 2026 [1]. - All other details in the original announcements dated January 2 and January 5 remain unchanged [1].

TABLE OF CONTENTS As filed with the Securities and Exchange Commission on December 5, 2025 Registration No. 333-283249 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO FORM F-1 REGISTRATION STATEMENT Under The Securities Act of 1933 Baird Medical Investment Holdings Limited (Exact name of Registrant as specified in its charter) (I.R.S. Employer Identification Number) The Cayman Islands 3711 Not Applicable (State or other jurisdiction of incorporation or organization ...

Core Viewpoint - Investors are concerned about Iren's new debt issuance and share offering, which led to a significant drop in the company's stock price by over 15% in one day [1]. Group 1: Debt Issuance - Iren plans to issue $2 billion worth of convertible, unsecured senior notes, divided into two tranches of $1 billion each [2]. - The first tranche will mature in 2032, and the second in 2033, with options for initial buyers to purchase an additional $150 million in each tranche [3]. - The notes will be convertible into ordinary shares, cash, or a combination of both, and are redeemable after December 6, 2028 [4]. Group 2: Share Offering - In addition to the debt issuance, Iren intends to issue ordinary shares in a registered direct offering, although the number of shares to be sold has not been specified [5]. Group 3: Financial Impact - The net proceeds from the debt and share offerings will be used to repurchase existing convertible notes and for general corporate purposes and working capital [7]. - As of the end of September, Iren's long-term debt was $964 million, with a market capitalization of $11.7 billion [7].

Core Viewpoint - Hofseth Biocare ASA ("HBC" or "the Company") has announced the completion of a private placement of new shares and is initiating a subsequent offering of up to 16,666,666 new Ordinary Shares at the same subscription price as the private placement [2][4]. Group 1: Private Placement and Subsequent Offering - The private placement was completed on 27 October 2025, and the terms for the subsequent offering were announced on 7 November 2025 [2]. - The subscription period for the subsequent offering starts on 10 November 2025 at 09:00 (CET) and ends on 20 November 2025 at 16:30 (CET) [4]. - The Company has prepared a national prospectus in accordance with the Norwegian Securities Trading Act, which has been registered and is available on the Company's website [3]. Group 2: Legal and Regulatory Information - The announcement clarifies that it does not constitute an offer to sell or a solicitation to purchase any securities of the Company [5][12]. - The securities mentioned have not been registered under the U.S. Securities Act and may not be offered or sold in the United States without registration or an applicable exemption [6]. - The communication is directed only at qualified investors in the EEA Member States and relevant persons in the United Kingdom [7][8].

Core Points - PayPoint plc successfully passed all resolutions at the General Meeting, including the approval of a Special Dividend and Share Consolidation [2][3] - The voting results showed overwhelming support for the resolutions, with the Special Dividend receiving 99.94% approval [3] - The Share Consolidation will result in shareholders receiving 12 New Ordinary Shares for every 13 Existing Ordinary Shares held, effective from 20 October 2025 [6] Voting Results - Resolution 1 (Special Dividend and Share Consolidation): 55,000,050 votes for (99.94%), 33,778 votes against (0.06%) [3] - Resolution 2 (Allotting shares): 54,782,132 votes for (99.55%), 244,953 votes against (0.45%) [3] - Resolution 3 (Disapply pre-emption rights): 54,737,260 votes for (99.48%), 286,713 votes against (0.52%) [3] - Resolution 4 (Disapply pre-emption rights for acquisitions): 53,706,157 votes for (97.60%), 1,319,717 votes against (2.40%) [3] - Resolution 5 (Market purchases of shares): 52,708,547 votes for (95.85%), 2,282,727 votes against (4.15%) [3] Share Capital Information - As of 15 October 2025, PayPoint had 69,020,204 ordinary shares in issue, with one vote per share [5] - Following a buyback and cancellation, the issued share capital will be 69,020,198 ordinary shares as of 17 October 2025 [5] Share Consolidation Details - The Share Consolidation will be effective as of 6:00 p.m. on 17 October 2025, with new shares trading on the London Stock Exchange starting 20 October 2025 [6]

Core Viewpoint - OSB Group PLC has announced the purchase of 119,220 ordinary shares as part of its share buyback program, which will be cancelled following the settlement of these purchases, resulting in a total of 359,639,905 ordinary shares in issue [3][5]. Summary by Sections Share Buyback Details - On October 10, 2025, OSB Group PLC purchased a total of 119,220 ordinary shares at prices ranging from 551.00p to 560.00p, with a volume-weighted average price of 554.64p [3][4]. - The share buyback program was initially announced on March 13, 2025 [4]. Trading Venue and Prices - The shares were purchased on the London Stock Exchange, CBOE BXE, and CBOE CX, with the highest price paid being 560.00p and the lowest at 551.00p [4]. - The detailed breakdown of individual trades conducted by Citigroup Global Markets Limited on behalf of the company is provided, showing various transactions at different prices and volumes [6][8]. Impact on Shares and Voting Rights - Following the cancellation of the repurchased shares, the total number of ordinary shares in issue will be 359,639,905, with no shares held in treasury, thus maintaining the same number of voting rights [5].